Creating a world without cancer
At the OHSU Knight Cancer Institute, a world-class team of doctors and scientists is working to end cancer in three ways: through early detection, immunotherapy and precision medicine.
That’s because when we find cancer earlier, people live longer. When we empower the immune system to attack cancer cells, we reduce the need for toxic therapies. And when we find a patient’s exact cancer mutation, we can use personalized treatments that offer more hope for a positive outcome.
This multifaceted approach has made the Knight Cancer Institute an international leader in research and cancer treatment. Join them in their mission to end cancer as we know it.
Helping more patients survive more cancers
While cancer takes on many forms, one thing remains constant: the Knight Cancer Institute’s commitment to transforming cancer care, no matter what the diagnosis. No other place in Oregon offers such a wide range of expertise for so many different types of cancers—here are just a few of the areas where the institute is making an impact:
The Knight Cancer Institute offers the most advanced care possible for blood cancers like leukemia, lymphoma and myeloma. It’s led by Director Brian Druker, M.D., whose pioneering research resulted in the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed. Knight Cancer Institute researchers also helped develop CAR T-cell therapy, which modifies a patient’s own blood cells to fight certain types of leukemia and lymphoma.
Researchers at the Knight Cancer Institute have built a groundbreaking clinical trial platform called SMMART, which uses a combination of targeted drugs to stop tumors before they can adapt and become drug-resistant. Currently, the team is focusing on metastatic breast cancer—and so far, results have exceeded expectations.
Prostate cancer is the second most common cancer in U.S. men, yet the treatment options have been historically limited. The Knight Cancer Institute gives patients options they wouldn’t otherwise have through promising clinical trials. The institute was also the first center in Oregon to offer Calypso radiation therapy, a system that directs focused therapy while sparing healthy tissue.
Get in Touch
For more information on how you can make a difference for the Knight Cancer Institute, please contact Caitlin Wilson:
Clinician Spotlight: Flavio Rocha, M.D., FACS, FSSO
Get to know Hedinger Chair and Chief of Surgical Oncology Flavio Rocha, M.D. Dr. Rocha shares what makes the surgeon-patient relationship so unique.
It’s a simple fact: the earlier cancer is found, the higher the chance of survival. That’s why OHSU has joined a prestigious national study to detect and stop lethal cancers at the earliest stage. The PATHFINDER study is evaluating a test that’s designed to detect multiple types of cancer through a single blood draw.
Cancer is personal. Behind every diagnosis there is a person, a story, and a reason to keep working on the biggest challenges in cancer science and care. A donation to the OHSU Knight Cancer Institute is a thoughtful way to honor someone special whose life has been impacted by cancer. Your gift can recognize milestones in a cancer survivor’s journey or celebrate their memory in a meaningful way.